Back to Search Start Over

Risk of Suicidal Ideation Lower With Semaglutide vs Other Obesity, T2D Drugs

Authors :
Ernst, Diana
Source :
MPR Monthly Prescribing Reference. January 6, 2024
Publication Year :
2024

Abstract

Semaglutide does not appear to increase the risk of suicidal ideation compared with non-glucagon-like peptide 1 receptor agonist (GLP-1RA) medications for obesity and diabetes, according to a retrospective cohort study [...]

Subjects

Subjects :
United States. National Institutes of Health
Suicidal behavior -- Drug therapy -- Risk factors
Obesity -- Drug therapy -- Risk factors
Drugs
Health

Details

Language :
English
ISSN :
08830266
Database :
Gale General OneFile
Journal :
MPR Monthly Prescribing Reference
Publication Type :
Periodical
Accession number :
edsgcl.778378285

Tools

Authors Abstract Subjects Details